Krystal Biotech
KRYS
KRYS
264 hedge funds and large institutions have $4.35B invested in Krystal Biotech in 2024 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 95 increasing their positions, 97 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 282 → 264 (-18)
15% less capital invested
Capital invested by funds: $5.15B → $4.35B (-$796M)
27% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 51
Holders
264
Holding in Top 10
6
Calls
$63.3M
Puts
$36.8M
Top Buyers
| 1 | +$22.2M | |
| 2 | +$11.2M | |
| 3 | +$10.1M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$10M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$8.62M |
Top Sellers
| 1 | -$31.3M | |
| 2 | -$27.2M | |
| 3 | -$16.7M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$14.2M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$12.8M |